Prostaglandin E2, leukotriene C4, and platelet-activating factor receptor sites in the brain. Binding parameters and pharmacological studies.
Dray
F
F
Unité de Radioimmunologie Analytique, Institut Pasteur/INSERM, Paris, France.
Wisner
A
A
Bommelaer-Bayet
M C
MC
Tiberghien
C
C
Gerozissis
K
K
Saadi
M
M
Junier
M P
MP
Rougeot
C
C
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D015232:Dinoprostone / Q000378:metabolism* / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000378:metabolism*; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface / Q000378:metabolism*; D043562:Receptors, G-Protein-Coupled; D011971:Receptors, Immunologic / Q000378:metabolism*; D018077:Receptors, Leukotriene; D011982:Receptors, Prostaglandin / Q000378:metabolism*; D018078:Receptors, Prostaglandin E; D013189:SRS-A / Q000378:metabolism* / Q000494:pharmacology
D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D011971:Receptors, Immunologic; D018077:Receptors, Leukotriene; D011982:Receptors, Prostaglandin; D018078:Receptors, Prostaglandin E; D013189:SRS-A; C039351:platelet activating factor receptor; D015232:Dinoprostone